Premium
Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution.
Author(s) -
Lewis LD,
Fowle AS,
Bittiner SB,
Bye A.,
Isaacs PE
Publication year - 1986
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1986.tb05223.x
Subject(s) - duodenum , cmax , radioimmunoassay , urine , pharmacokinetics , absorption (acoustics) , chemistry , medicine , endocrinology , physics , acoustics
On two occasions at least 1 week apart, nine healthy male volunteers were administered in random order either 2 X 200 mg (1.8 mmol) acyclovir tablets or 400 mg of acyclovir in 500 ml of 5% dextrose solution which was infused at constant rate into the duodenum over 4 h. Six of the subjects subsequently sipped the same solution at the rate of 10.4 ml in each 5 min period for 4 h. Blood and urine were sampled over 24 h for each mode of administration. Acyclovir was assayed by radioimmunoassay. Mean areas under the plasma concentration‐time curves (AUCs) +/‐ s.d. for tablet (T), intraduodenal infusion (I) and sipping (S) were, respectively: T = 14.7 +/‐ 5.1; I = 24.6 +/‐ 5.1; S = 28.4 +/‐ 9.5 (n = 6) mumol l‐1 h. AUCs for I and S were significantly greater than that for T (2P less than 0.05). Mean apparent maximum plasma concentrations (Cmax) +/‐ s.d. were T = 3.8 +/‐ 1.5; I = 4.8 +/‐ 0.9; S = 5.1 +/‐ 1.5 mumol l‐1. This trend to higher values for I and S was not significant. Mean apparent plasma disappearance half‐lives (t1/2) +/‐ s.d. were respectively T = 2.3 +/‐ 0.4; I = 2.7 +/‐ 0.5; S = 3.0 +/‐ 0.2 h, I being significantly greater than T (2P less than 0.05), as was S greater than T (2P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)